Related references
Note: Only part of the references are listed.Ivermectin for the Treatment of Coronavirus Disease 2019: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Yuani M. Roman et al.
CLINICAL INFECTIOUS DISEASES (2022)
Serious adverse events with tocilizumab: Pharmacovigilance as an aid to prioritize monitoring in COVID-19
Milo Gatti et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Abnormal laboratory findings and plasma concentration monitoring of lopinavir and ritonavir in COVID-19
Benjamin Batteux et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Late onset infectious complications and safety of tocilizumab in the management of COVID-19
Natasha N. Pettit et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Inhaled nitric oxide minimally improves oxygenation in COVID-19 related acute respiratory distress syndrome
Alessia Longobardo et al.
BRITISH JOURNAL OF ANAESTHESIA (2021)
Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019 The Ivermectin in COVID Nineteen Study
Juliana Cepelowicz Rajter et al.
CHEST (2021)
Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019
Richard M. Burwick et al.
CLINICAL INFECTIOUS DISEASES (2021)
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis
Thibault Fiolet et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Spontaneous reported cardiotoxicity induced by lopinavir/ritonavir in COVID-19. An alleged past-resolved problem
Audrey Fresse et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2021)
Remdesivir: A potential game-changer or just a myth? A systematic review and meta-analysis
Dhan Bahadur Shrestha et al.
LIFE SCIENCES (2021)
Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
A. C. Kalil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Impact of Corticosteroids in Coronavirus Disease 2019 Outcomes Systematic Review and Meta-analysis
Edison J. Cano et al.
CHEST (2021)
Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19 A Randomized Clinical Trial
Eduardo Lopez-Medina et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Hydroxychloroquine as a primary prophylactic agent against SARS-CoV-2 infection: A cohort study
Peter Kamstrup et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial
Carlos Chaccour et al.
ECLINICALMEDICINE (2021)
Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19
Bhagteshwar Singh et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)
Ivermectin for preventing and treating COVID-19
Maria Popp et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)
The broad spectrum antiviral ivermectin targets the host nuclear transport importin alpha/beta 1 heterodimer
Sundy N. Y. Yang et al.
ANTIVIRAL RESEARCH (2020)
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore
Barnaby Edward Young et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
COVID-19 in a designated infectious diseases hospital outside Hubei Province, China
Qingxian Cai et al.
ALLERGY (2020)
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
Paola Toniati et al.
AUTOIMMUNITY REVIEWS (2020)
The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients
Steven P. Treon et al.
BLOOD (2020)
COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options
Tomasz J. Guzik et al.
CARDIOVASCULAR RESEARCH (2020)
Cardiovascular Toxicities Associated With Hydroxychloroquine and Azithromycin An Analysis of the World Health Organization Pharmacovigilance Database
Lee S. Nguyen et al.
CIRCULATION (2020)
Guidance for Cardiac Electrophysiology During the COVID-19 Pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association
Dhanunjaya R. Lakkireddy et al.
CIRCULATION (2020)
Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study
N. Lian et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State
Eli S. Rosenberg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19) A Review
James M. Sanders et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial
Yang Cao et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Effective treatment of severe COVID-19 patients with tocilizumab
Xiaoling Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis
Zhenwei Yang et al.
JOURNAL OF INFECTION (2020)
Tocilizumab for the treatment of severe coronavirus disease 2019
Rand Alattar et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Off-label use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers
Alexandre Gerard et al.
THERAPIE (2020)
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
Philippe Gautret et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
Wei Tang et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data
Matthieu Mahevas et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
Chaomin Wu et al.
JAMA INTERNAL MEDICINE (2020)
Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)
Nicholas J. Mercuro et al.
JAMA CARDIOLOGY (2020)
Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit
Francis Bessiere et al.
JAMA CARDIOLOGY (2020)
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Jason D. Goldman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Compassionate Use of Remdesivir for Patients with Severe Covid-19
J. Grein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019
Ashley Barlow et al.
PHARMACOTHERAPY (2020)
Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019
Francois Montastruc et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Finding the Dose for Hydroxychloroquine Prophylaxis for COVID-19: The Desperate Search for Effectiveness
Mahmoud Al-Kofahi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Leon Caly et al.
ANTIVIRAL RESEARCH (2020)
Postdischarge venous thromboembolism following hospital admission with COVID-19
Lara N. Roberts et al.
BLOOD (2020)
Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis
Wei Liu et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2020)
Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression
Fang Liu et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Coronavirus Disease 2019 (COVID-19) and Transplantation: Pharmacotherapeutic Management of Immunosuppression Regimen
Mahtabalsadat Mirjalili et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2020)
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) A Review
W. Joost Wiersinga et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
COVID-19 and Dexamethasone A Potential Strategy to Avoid Steroid-Related Strongyloides Hyperinfection
William M. Stauffer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study
Oscar Moreno-Perez et al.
JOURNAL OF AUTOIMMUNITY (2020)
Inhibition of Bruton tyrosine kinase in patients with severe COVID-19
Mark Roschewski et al.
SCIENCE IMMUNOLOGY (2020)
Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection A Randomized Clinical Trial
Mayla Gabriela Silva Borba et al.
JAMA NETWORK OPEN (2020)
First case of drug-induced liver injury associated with the use of tocilizumab in a patient with COVID-19
Damir Muhovic et al.
LIVER INTERNATIONAL (2020)
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
David R. Boulware et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status
Spinello Antinori et al.
PHARMACOLOGICAL RESEARCH (2020)
Drug treatments for covid-19: living systematic review and network meta-analysis
Reed A. C. Siemieniuk et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19 A Randomized Clinical Trial
Pierre-Francois Dequin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19 The CoDEX Randomized Clinical Trial
Bruno M. Tomazini et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19 The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial
Derek C. Angus et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 A Meta-analysis
Jonathan A. C. Sterne et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
Peter Horby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A living WHO guideline on drugs for covid-19
Francois Lamontagne et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Ocular Findings in COVID-19 Patients: A Review of Direct Manifestations and Indirect Effects on the Eye
Federica Bertoli et al.
JOURNAL OF OPHTHALMOLOGY (2020)
Remdesivir Treatment for Severe COVID-19 in Third-Trimester Pregnancy: Case Report and Management Discussion
Grace A. Maldarelli et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID)
Anna Cristina Bertoldi Lemos et al.
THROMBOSIS RESEARCH (2020)
Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial
Yueping Li et al.
MED (2020)
Interferon β-1b in treatment of severe COVID-19: A randomized clinical trial
Hamid Rahmani et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
The role of Interleukin 6 inhibitors in therapy of severe COVID-19
E. Nasonov et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysis
Stephan Nopp et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)
Emerging and experimental treatments for COVID-19 and drug interactions with psychotropic agents
Delia Bishara et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2020)
COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?
Beth Russell et al.
ECANCERMEDICALSCIENCE (2020)
Pregnancy outcomes from the global pharmacovigilance database on interferon beta-1b exposure
Kerstin Hellwig et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2020)
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
Sabue Mulangu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The association between exposure to interferon-beta during pregnancy and birth measurements in offspring of women with multiple sclerosis
Sarah Burkill et al.
PLOS ONE (2019)
Safety and pharmacokinetic profile of fixed-dose ivermectin with an innovative 18mg tablet in healthy adult volunteers
Jose Munoz et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
Pulmonary arterial hypertension in patients treated with interferon
Laurent Savale et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Periprocedural Management of Antithrombotic Therapy in Hospitalized Patients
David Feinbloom
JOURNAL OF HOSPITAL MEDICINE (2014)
Toxicogenetics of lopinavir/ritonavir in HIV-infected European patients
Elena Lopez Aspiroz et al.
PERSONALIZED MEDICINE (2014)
Ivermectin: panacea for resource-poor communities?
Satoshi Omura et al.
TRENDS IN PARASITOLOGY (2014)
Fueling autoimmunity: type I interferon in autoimmune diseases
Jeremy Di Domizio et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2013)
Risk of acute kidney injury in patients who undergo coronary angiography and cardiac surgery in close succession
Byungsoo Ko et al.
EUROPEAN HEART JOURNAL (2012)
Probable Corticosteroid-Induced Reactivation of Latent Hepatitis B Virus Infection in an HIV-Positive Patient Involving Immune Escape
Nora Martel et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Interferons in Autoimmune and Inflammatory Diseases: Regulation and Roles
Divaker Choubey et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2011)
Psychiatric adverse effects of corticosteroids
Thomas P. Warrington et al.
MAYO CLINIC PROCEEDINGS (2006)
SARS: Systematic review of treatment effects
Lauren J. Stockman et al.
PLOS MEDICINE (2006)
Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers
Daniel J. Brotman et al.
THROMBOSIS RESEARCH (2006)
Bruton's tyrosine kinase phosphorylates cAMP-responsive element-binding protein at serine 133 during neuronal differentiation in immortalized hippocampal progenitor cells
EJ Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects
CA Guzzo et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Share Paper
